cataplexy


Also found in: Medical, Encyclopedia, Wikipedia.

cat·a·plex·y

 (kăt′ə-plĕk′sē)
n. pl. cat·a·plex·ies
A sudden loss of muscle tone and strength, usually caused by an extreme emotional stimulus.

[From Greek kataplēxis, fixation (of the eyes), from kataplēssein, to astound, terrify : kata-, intensive pref.; see cata- + plēssein, plēk-, to strike; see plāk- in Indo-European roots.]

cat′a·plec′tic (-plĕk′tĭk) adj.

cataplexy

(ˈkætəˌplɛksɪ)
n
1. (Pathology) sudden temporary paralysis, brought on by severe shock
2. (Zoology) a state of complete absence of movement assumed by animals while shamming death
[C19: from Greek kataplēxis amazement, from kataplēssein to strike down (with amazement), confound, from kata- down + plēssein to strike]
ˌcataˈplectic adj

cataplexy

a temporary paralytic or hypnotic state, often brought on by strong emotion. — cataplectic, adj.
See also: Nerves
Translations

cat·a·plex·y

n. cataplejía, pérdida repentina del tono muscular causada por un estado emocional intenso.

cataplexy

n cataplexia
Mentioned in ?
References in periodicals archive ?
Narcolepsy is a prolonged neurological disorder related to excessive daytime sleepiness (EDS), cataplexy, hypnagogic hallucinations, sleep paralysis, and fragmented night sleep.
'Our top priority is the continued advancement of FT218, our proprietary once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy associated with narcolepsy.
(4) Idiopathic hypersomnia is characterized by EDS that occurs in the absence of cataplexy and is accompanied by no more than 1 sleep-onset REM (SOREM) period on an MSLT and the preceding PSG combined.
This disorder is typically characterised by excessive daytime sleepiness and cataplexy (sudden muscle weakness triggered by emotion), among other symptoms.
Using a wheelchair and unable to speak, Charlie lives with brain disorders epilepsy, narcolepsy and cataplexy - all severe conditions in themselves.
Avadel Pharmaceuticals pic is restructuring to assure funds required to focus on its FT218 clinical program, currently in Phase HI development for the treatment of excessive daytime sleepiness (EDS) and Cataplexy in patients suffering from Narcolepsy.
Narcolepsy type 1 is a rare disabling sleep disorder mainly characterized by excessive daytime sleepiness and cataplexy, an emotion-triggered sudden loss of muscle tone [1,2].
Cataplexy: The weakening of muscles when you feel strong emotions like embarrassment, laughter, surprise, or anger.
Xyrem has been the only approved treatment for both excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Narcolepsy is characterized by excessive sleepiness, cataplexy, hypnagogic hallucinations, and sleep paralysis during the rapid eye movement period of sleep.